Open Access · CC BY-NC-ND 4.0
99Tc-Tilmanocept sentinel node biopsy and long-term outcomes in melanoma
EJC Skin Cancer · 2026 · 4 · 100786
DOI: 10.1016/j.ejcskn.2026.100786 ↗Kurz gefasst
Fachartikel in der Zeitschrift EJC Skin Cancer, 2026. Verfasst von A. Roshan und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Roshan, A., Pasha, T., Kounidas, G., O'Leary, F., Murphy, S., Tajsic, T., Patel, A., Aloj, L., Buscombe, J., & Durrani, A. (2026). 99Tc-Tilmanocept sentinel node biopsy and long-term outcomes in melanoma. EJC Skin Cancer, 4, 100786. https://doi.org/10.1016/j.ejcskn.2026.100786
Vancouver
Roshan A, Pasha T, Kounidas G, O'Leary F, Murphy S, Tajsic T, et al. 99Tc-Tilmanocept sentinel node biopsy and long-term outcomes in melanoma. EJC Skin Cancer. 2026;4:100786. doi:10.1016/j.ejcskn.2026.100786
BibTeX
@article{Roshan2026,
author = {Roshan, A. and Pasha, T. and Kounidas, G. and O'Leary, F. and Murphy, S. and Tajsic, T. and Patel, A. and Aloj, L. and Buscombe, J. and Durrani, A.},
title = {99Tc-Tilmanocept sentinel node biopsy and long-term outcomes in melanoma},
journal = {EJC Skin Cancer},
year = {2026},
volume = {4},
pages = {100786},
doi = {10.1016/j.ejcskn.2026.100786}
}
EUVIMED